The innate alarm system in PTSD: conscious and subconscious processing of threat.
Ruth A Lanius, Daniela Rabellino, Jenna E Boyd...
https://pubmed.ncbi.nlm.nih.gov/28813307/Actively Recruiting
Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2026-11-03
234
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the effectiveness of Deep Brain Reorienting DBR therapy in reducing symptoms of Post-traumatic Stress Disorder PTSD. This trial compares the DBR treatment to a wait-list control group. DBR is a trauma therapy developed to help process traumatic memories by focusing on muscle tensions involved in orienting toward perceived threats, potentially altering how trauma is accessed in the brains defensive system. The study includes two phases, with the second phase focusing specifically on military veterans. Participants in the DBR treatment group receive eight weekly sessions where they are guided to attend to physical tensions related to trauma, aiming to manage emotional responses safely. Those in the wait-list condition do not receive intervention for about eight weeks. Assessments are conducted both online via video conferencing and in person, including clinical interviews and functional MRI scans before and after treatment. During the study, participants undergo clinical interviews and brain imaging to measure changes in PTSD symptoms using the Clinician Administered PTSD Scale CAPS at baseline, after treatment 8 weeks, and at a 3-month follow-up. The study is randomized with single masking, and researchers monitor participants to assess how DBR may impact PTSD symptoms over time. Participation lasts through treatment and follow-up assessments up to three months after treatment ends.
CONDITIONS
Deep Brain Reorienting in Post-traumatic Stress Disorder
S
Suzy - Study Coordinator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 baseline visit (in-person or online)
Duration - 8 weeks
Participants receive eight weekly sessions of Deep Brain Reorienting therapy or no intervention during this period.
Weekly visits
Duration - 3 months
Participants complete follow-up assessments including clinical interviews and brain imaging to measure changes in PTSD symptoms.
1 follow-up visit
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ruth A Lanius, Daniela Rabellino, Jenna E Boyd...
https://pubmed.ncbi.nlm.nih.gov/28813307/Breanne E Kearney, Frank M Corrigan, Paul A Frewen...
https://pubmed.ncbi.nlm.nih.gov/37581275/Brian D Corneil, Douglas P Munoz, Brendan B Chapman...
https://pubmed.ncbi.nlm.nih.gov/18059264/Braeden A Terpou, Maria Densmore, Janine Thome...
https://pubmed.ncbi.nlm.nih.gov/32440590/Eliane Comoli, Plínio Das Neves Favaro, Nicolas Vautrelle...
https://pubmed.ncbi.nlm.nih.gov/22514521/London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor